Transfer of innovation and knowledge: 3D Cell Culture Conference 2023
In April, our CEO Martin Raasch and our scientists Anne-Katrin Bothe and Tim Kaden attended the 3D Cell Culture Conference in Freiburg.
In April, our CEO Martin Raasch and our scientists Anne-Katrin Bothe and Tim Kaden attended the 3D Cell Culture Conference in Freiburg.
Dynamic42 is one of the chosen companies and research groups receiving funding from of the Sanofi iDEA-iTECH Award.
Dynamic42 GmbH is celebrating its fifth anniversary this spring. The last few years have been characterised by continuous growth, professionalisation and forward-looking innovations.
Science is our passion. That's why we invest in the next generation of scientists. Meet our Master's students Sophie and Daria.
With the help of organ models, we are already increasing drug safety and advancing approaches for individualized medicine.
Meet our Lab Manager Katja Graf: I am proud to be involved in developing and commercializing a pioneering technology such as organ-on-chip.
Senior Scientist Dr. Rizwan Rehimi joined Dynamic42 for a joint project with the Institute of Pharmaceutical Biology and Biotechnology at Heinrich Heine University.
With the registration of Dynamic42 as a trademark, we are setting an example in the direction of future viability and growth.
We recently celebrated our fourth company birthday. Time to look back and at the same time look forward with excitement to new developments.
We are looking forward to two new colleagues for our research and laboratory team!